Description:

Gynecologic Oncology Group Pathology Form (Form F) Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=624516DD-721D-10AB-E040-BB89AD434B50

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=624516DD-721D-10AB-E040-BB89AD434B50

Keywords:
Versions (2) ▾
  1. 9/19/12
  2. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Fallopian Tube Cancer NCT00951496 Pathology - Gynecologic Oncology Group Pathology Form (Form F) - 2834756v1.0

No Instruction available.

  1. StudyEvent: Gynecologic Oncology Group Pathology Form (Form F)
    1. No Instruction available.
Header Module
Primary Disease Assessment
Primary Site
Method of evaluation
Histologic Type (check one)
Histologic grade (Differentiation)
Specimen Site
Secondary Disease Assessment
Method of evaluation
Disease Status
Specimen Site

Similar models